Autonomous CEO, Dr. Ariel Weinberger, gives plenary presentation at NIH Synthetic Biology Consortium Meeting

Dr. Weinberger was invited to present Autonomous’ next-generation encrypted RNA technology and also served on a plenary panel with leaders from FDA, ARPA-H, University of Washington, and Gingko Bioworks.